These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8216716)

  • 1. Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry.
    Lidin B; Gartland L; Marshall G; Sanchez V; Lamon EW
    Viral Immunol; 1993; 6(2):97-107. PubMed ID: 8216716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus.
    Lidin B; Lamon EW
    Antiviral Res; 1992 Jan; 17(1):79-89. PubMed ID: 1371044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel early antigen associated with Epstein-Barr virus productive cycle.
    Freemer CS; Bertoni G; Takagi S; Sairenji T
    Virology; 1993 May; 194(1):387-92. PubMed ID: 8386883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody.
    Lin JC; Choi EI; Pagano JS
    J Virol; 1985 Mar; 53(3):793-9. PubMed ID: 2983091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of D and R components of Epstein-Barr virus early antigen after superinfection and after induction with 5-iododeoxyuridine.
    Simonová I; Závadová H; Vonka V
    Acta Virol; 1977 May; 21(3):184-8. PubMed ID: 18915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of Epstein-Barr virus (EBV) BMRF1 protein EA-D during latent EBV activation of Burkitt's lymphoma cell line Raji.
    Ohashi M; Horie K; Hoshikawa Y; Nagata K; Osaki M; Ito H; Sairenji T
    Microbes Infect; 2007 Feb; 9(2):150-9. PubMed ID: 17223371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
    J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon enhances the expression of epstein-Barr virus early antigen in Daudi cells.
    Tovey MG; Dron M; Gresser I
    J Gen Virol; 1982 May; 60(Pt 1):31-8. PubMed ID: 6178801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Epstein-Barr virus-induced early polypeptide complex p50/58 EA-D using rabbit antisera, a monoclonal antibody, and human antibodies.
    Dölken G; Hecht T; Röckel D; Hirsch FW
    Virology; 1987 Apr; 157(2):460-71. PubMed ID: 3029983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
    Klein G; Clements G; Zeuthen J; Westman A
    Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation between infecting Epstein-Barr virus and intrinsic viral genomes in human lymphoid cell lines.
    Lidin BI; Lamon EW; Cloud G; Soong SJ
    Intervirology; 1982; 18(1-2):66-75. PubMed ID: 6288617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of a polypeptide complex (p52) belonging to the D-subspecificites of Epstein-Barr virus-induced early antigens.
    Dölken G; Hecht T; Weitzmann U; Wagner M; Löhr GW; Hirsch FW
    Virology; 1986 Jan; 148(1):58-73. PubMed ID: 3002036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.